Skip to content Skip to search Skip to footer
WashU Medicine

Dominantly Inherited Alzheimer Network (DIAN)

Menu
  • Join the Registry
    • Individuals & Families
    • Researchers & Health Professionals
  • For Families
    • Genetic Counseling & Testing
    • Family Conferences
    • Video Gallery
    • Family Voices
    • DIAN in Latin America
    • EXR Newsletter
    • Webinars
    • Resources
    • Brain Donation
    • Message from Our Directors
  • Observational Study
    • Obs Study Sites
    • Study Description
    • Participation
    • Procedures
    • Advisory & Steering Committee
    • Funding: DIAN Obs Study
  • Clinical Trials
    • TU Participating Sites
    • Primary Prevention Trial
    • Secondary Prevention Trial
    • Research Updates
    • Funding
    • DIAN-TU History
  • Our Research
    • For Investigators
    • Our Collaborators
    • Research Fellows
    • DIAN Symposium
    • Pharma Consortium
    • Publications
    • Latin America Expansion
  • About us
    • The DIAN Team
    • Committees
    • Contact
  • News & Updates

Category: Advancements in Alzheimers disease

Conquering Alzheimer’s: a look at the therapies of the future (Links to an external site)

April 7, 2023

Focused ultrasound technique leads to release of neurodegenerative disorders biomarkers (Links to an external site)

February 3, 2023February 3, 2023

FDA APPROVES LEQEMBI™ (LECANEMAB-IRMB) UNDER THE ACCELERATED APPROVAL PATHWAY FOR THE TREATMENT OF ALZHEIMER’S DISEASE (Links to an external site)

January 7, 2023

WashU, Eisai form drug discovery collaboration (Links to an external site)

December 16, 2022

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III GRADUATE programme evaluating gantenerumab in early Alzheimer’s disease (Links to an external site)

November 15, 2022

LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT, SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN LARGE GLOBAL CLINICAL STUDY OF 1,795 PARTICIPANTS WITH EARLY ALZHEIMER’S DISEASE (Links to an external site)

September 28, 2022

Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease (Links to an external site)

June 16, 2022

Blood test for Alzheimer’s highly accurate in large, international study (Links to an external site)

February 23, 2022

Dementia First blood test to help diagnose Alzheimer’s goes on sale (Links to an external site)

December 7, 2020March 23, 2021

Why Didn’t She Get Alzheimer’s? The Answer Could Hold a Key to Fighting the Disease (Links to an external site)

November 4, 2019November 21, 2019

Posts navigation

Previous Page
2 of 3
Next Page

DIAN

Dominantly Inherited Alzheimer Network

WashU Medicine

660 S. Euclid Ave.

Campus Box 8111

St. Louis, MO 63110

 

Contact Us

Links

  • Investigator Resources
  • Current Participating Sites
  • DIAN Research Updates

Make a Difference

Your thoughtful contribution enables us to continue researching possible treatments and ultimately cures for this devastating disease.

DONATE

©2026 Washington University in St. Louis